Novartis Update: Supreme Court adjourns final hearing to 11 September 2012
22 August 2012, New Delhi. As directed by the Supreme Court of India on 10 July 2012, the petition filed by Novartis AG, challenging the Intellectual Property Appellate Board’s rejection of its appeal...
View ArticleHearing Update: Novartis argues that section 3(d) not applicable to its...
12 September 2012, New Delhi. Continuing arguments on behalf of Novartis, Mr Gopal Subramaniam, senior counsel, took the Bench through the Complete Specification of Novartis’ patent application for the...
View ArticleCurrent Cases
Novartis AG v. Union of India and Others, SLP (Civil) Nos. 20539–20549 of 2009 In this case, which is presently before the Supreme Court of India, Novartis AG (Novartis) challenges the order of the...
View ArticleNovartis case: background and update – Supreme Court of India to recommence...
Novartis case: background and update – Supreme Court of India to recommence hearing 5 September 2011, New Delhi. Tomorrow, a Division Bench of the Supreme Court of India, comprising Justice Dalveer...
View ArticleHearing Update: Novartis argues section 3(d) not intended to address issue of...
13 September 2012, New Delhi. Mr Subramaniam, senior counsel appearing for Novartis, continued his arguments today. Placing on record the Doha Declaration on TRIPS Agreement and Public Health, Mr...
View ArticleSouth Korean civil society groups welcome the ruling of the Supreme Court of...
[Novartis defeated in its appeal trial, a triumphant victory of World patients fighting back Patent Exclusivity] Welcome the ruling of the Supreme Court of India 1. The protracted Novartis’ appeal from...
View ArticleNovartis Ruling Reverberates Past India’s Borders
India’s Supreme Court says drug maker Novartis can’t hold onto its patent for the pricey cancer drug Gleevec simply by tweaking its chemical formula. That means generic drug makers can keep making a...
View ArticleIndian Civil Society Members Urge Prime Minister to Resist US Administration...
March 27, 2014 Dr. Manmohan Singh Hon’ble Prime Minister of India, The Prime Minister’s Office, South Block, Raisina Hill, New Delhi 110011. Tel: 011 23018939; Fax: 011 2301 0233. Email:...
View ArticleNovartis Hearing Update: Supreme Court commences final hearing
11 September 2012, New Delhi. The final hearing of the petition filed by Novartis AG, challenging the order of the Intellectual Property Appellate Board (IPAB) rejecting its appeal relating to its...
View Article
